Georghiou P R, Blacklock Z M
Division of Specialised Health Services, Queensland Department of Health, Brisbane.
Med J Aust. 1992 May 18;156(10):692-7. doi: 10.5694/j.1326-5377.1992.tb121509.x.
To review the species distribution, pathologic significance and disease associations of clinical isolates of Nocardia and related bacteria in Queensland, and to examine the characteristics, treatment and outcome of patients infected with these organisms.
A retrospective review of Queensland State Health Laboratory records provided microbiological data for Nocardia isolates referred from other laboratories during the period January 1983 to December 1988. Clinical information was extracted from hospital case notes, or obtained from detailed questionnaires completed by attending physicians. Nocardia isolates were classified as "significant" if specific treatment for nocardiosis was given, or on the basis of autopsy findings.
One hundred and two patients had a Nocardia species or a related organism isolated from clinical specimens during the study period.
The 102 isolates included Nocardia asteroides (45), N, brasiliensis (35), N. caviae (5) and N. transvalensis (5). Clinical results were available for 93 patients, of whom 74 (80%) had a significant isolate recovered. Primary pulmonary or disseminated disease occurred in 35 patients, and was caused mainly by N. asteroides. Significant infections of skin and soft tissues, primarily due to N. brasiliensis, were found in 39 patients. Preexisting lung disease and treatment with steroids and immunosuppression were risk factors for pulmonary and disseminated nocardiosis. A history of inoculation in an outdoor setting was frequent in patients with cutaneous disease. Antibiotic regimens that included trimethoprim-sulfamethoxazole or another sulfonamide agent were used to treat the majority of patients with significant infection. Deaths were confined to those with pulmonary and disseminated disease, with a case fatality rate of 40% in that group.
Infection with Nocardia species appears to be more common than is generally appreciated. The local species distribution and disease spectrum are similar to those described elsewhere. A high index of suspicion for nocardiosis should be maintained in susceptible hosts with pulmonary infiltrates, particularly when there is evidence for metastatic infection, and in patients with superficial infections and a history of outdoor injury.
回顾昆士兰州诺卡菌及相关细菌临床分离株的种类分布、病理意义及疾病关联,并研究感染这些微生物的患者的特征、治疗及转归。
对昆士兰州卫生实验室记录进行回顾性分析,该记录提供了1983年1月至1988年12月期间从其他实验室送检的诺卡菌分离株的微生物学数据。临床信息从医院病历中提取,或通过主治医生填写的详细问卷获得。如果对诺卡菌病进行了特异性治疗,或根据尸检结果,诺卡菌分离株被分类为“有意义”。
在研究期间,102例患者的临床标本中分离出诺卡菌属或相关微生物。
102株分离株包括星形诺卡菌(45株)、巴西诺卡菌(35株)、豚鼠诺卡菌(5株)和德兰士瓦诺卡菌(5株)。93例患者有临床结果记录,其中74例(80%)分离出有意义的菌株。35例患者发生原发性肺部或播散性疾病,主要由星形诺卡菌引起。39例患者出现主要由巴西诺卡菌引起的皮肤和软组织严重感染。既往肺部疾病以及使用类固醇和免疫抑制剂治疗是肺部和播散性诺卡菌病的危险因素。皮肤病患者常有户外接种史。包括甲氧苄啶 - 磺胺甲恶唑或其他磺胺类药物的抗生素方案用于治疗大多数严重感染患者。死亡仅限于肺部和播散性疾病患者,该组病死率为40%。
诺卡菌感染似乎比普遍认为的更为常见。当地的菌种分布和疾病谱与其他地方描述的相似。对于有肺部浸润的易感宿主,尤其是有转移性感染证据时,以及有浅表感染和户外受伤史的患者,应高度怀疑诺卡菌病。